Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1

2(33.3%)

N/A

2(33.3%)

Phase 2

1(16.7%)

Phase 3

1(16.7%)

6Total

Phase 1(2)

N/A(2)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06992180Not ApplicableNot Yet Recruiting

Generative Artificial Intelligence Intervention and Individual Psychological Counseling on Emotional Distress in Young Adults

Role: collaborator

NCT03010735Phase 2Completed

Effects of Probiotics on the Patients With End Stage Renal Disease (ESRD)

Role: lead

NCT03010696Completed

The Correlation Between Gut Microbiome/Metabolite and End Stage Renal Disease (ESRD)

Role: lead

NCT04570072Not ApplicableUnknown

Effect of Probiotic on Comorbidity of Depression and Constipation

Role: lead

NCT04567147Phase 1Completed

Effect of Probiotic on Depression

Role: lead

NCT04296825Phase 1Completed

Effect of Camel Milk With Probiotic on Type 2 Diabetes Mellitus

Role: lead

NCT03100851Phase 3Completed

Effect of Probiotic on Constipation

Role: lead

All 7 trials loaded